October 2025
1. ABDELHAK A, Cerono G, Sheikhzadeh F, Harroud A, et al
   Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.
   Nat Med. 2025 Oct 20. doi: 10.1038/s41591-025-04014.
   

   >> Share

   
   August 2025
2. GANJGAHI H, Haring DA, Aarden P, Graham G, et al
   AI-driven reclassification of multiple sclerosis progression.
   Nat Med. 2025 Aug 20. doi: 10.1038/s41591-025-03901.
   

   >> Share

   
   April 2025
3. KLOTZ L, Smolders J, Lehto J, Matilainen M, et al
   Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis.
   Nat Med. 2025 Apr 29. doi: 10.1038/s41591-025-03625.
   

   >> Share

   
   July 2024
4. MEI F, Fancy SPJ, Shen YA, Niu J, et al
   Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
   Nat Med. 2024 Jul 12. doi: 10.1038/s41591-024-03162.
   

   >> Share

   
   April 2024
5. ZAMECNIK CR, Sowa GM, Abdelhak A, Dandekar R, et al
   An autoantibody signature predictive for multiple sclerosis.
   Nat Med. 2024 Apr 19. doi: 10.1038/s41591-024-02938.
   

   >> Share

   
   
6. ARNOLD C
   'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to celiac disease.
   Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
   

   >> Share

   
   July 2023
7. CARVALHO T
   Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis.
   Nat Med. 2023 Jul 5. doi: 10.1038/d41591-023-00060.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share